안과 분야 수탁연구기관(CRO) 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global ophthalmology contract research organization market size is expected to reach USD 7.05 Billion in 2034 from USD 3.40 Billion in 2025, growing at a CAGR of 8.44 during 2026-2034.This market is experiencing significant growth due to increasing clinical research activities focused on eye diseases and vision-related disorders. Ophthalmology contract research organizations provide specialized services for clinical trial management, regulatory support, patient recruitment, and data analysis. Rising prevalence of conditions such as glaucoma, cataracts, diabetic retinopathy, and age-related macular degeneration is driving demand for innovative therapies. Pharmaceutical and biotechnology companies are increasingly outsourcing research activities to improve efficiency and reduce development timelines.

Advancements in ophthalmic drug development and medical devices are creating strong demand for specialized research expertise. Contract research organizations offer access to experienced investigators, advanced technologies, and global trial networks that accelerate clinical development. Growing investments in biologics, gene therapies, and targeted ophthalmic treatments are further supporting market expansion. Regulatory requirements for comprehensive clinical evaluations are also encouraging partnerships with specialized research providers.

Future prospects remain highly favorable as the global burden of eye diseases continues to increase. Emerging therapies, precision medicine approaches, and digital clinical trial technologies will create additional opportunities for market participants. Expansion of clinical research activities in emerging economies is expected to strengthen market growth. As innovation in ophthalmology advances, contract research organizations will play an increasingly important role in bringing new treatments to market.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Service Type

• Early Phase Development Services (Preclinical Trials, Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, Toxicology Studies, First-In-Human (FIH) Studies, Formulation Development)
• Clinical Research (Phase I Trials, Phase II Trials, Phase III Trials, Phase IV (Post-Marketing Surveillance), Site Management, Patient Recruitment and Retention)
• Laboratory Services (Bioanalytical Testing, Biomarker Analysis, Central Laboratory Services, Histopathology, Genomic and Proteomic Services)
• Regulatory Consulting Services (Regulatory Strategy Development, Investigational New Drug or Clinical Trial Application Preparation and Submission, Regulatory Writing and Documentation, Health Authority Meeting Support, Labeling and Compliance Consulting)

By Therapy

• Traditional Interventions
• Anti-Inflammatory Interventions
• Corticosteroids
• Non-Steroidal Anti-Inflammatory Drugs
• Other Anti-Inflammatory Interventions
• Anti-Oxidative Interventions
• Other Traditional Interventions
• Advanced Interventions

By End User

• Pharma or Biopharma Companies
• Medical Device Companies
• Academic Institutes

COMPANIES PROFILED

• IQVIA Holdings Inc., ICON plc, Charles River Laboratories International, Inc., Eurofins Scientific SE, Syneos Health, Inc., Medpace Holdings, Inc., WuXi AppTec Co., Ltd., Parexel International Corporation, Fortrea Holdings Inc., Laboratory Corporation of America Holdings (Covance), SGS SA (SGS Life Sciences), PSI CRO AG, Worldwide Clinical Trials, Novotech Health Holdings Pty Limited, TFS HealthScience

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL OPHTHALMOLOGY CONTRACT RESEARCH ORGANIZATION MARKET: BY SERVICE TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Service Type
• 4.2. Early Phase Development Services (Preclinical Trials, Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, Toxicology Studies, First-In-Human (FIH) Studies, Formulation Development) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Clinical Research (Phase I Trials, Phase II Trials, Phase III Trials, Phase IV (Post-Marketing Surveillance), Site Management, Patient Recruitment and Retention) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Laboratory Services (Bioanalytical Testing, Biomarker Analysis, Central Laboratory Services, Histopathology, Genomic and Proteomic Services) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Regulatory Consulting Services (Regulatory Strategy Development, Investigational New Drug or Clinical Trial Application Preparation and Submission, Regulatory Writing and Documentation, Health Authority Meeting Support, Labeling and Compliance Consulting) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL OPHTHALMOLOGY CONTRACT RESEARCH ORGANIZATION MARKET: BY THERAPY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Therapy
• 5.2. Traditional Interventions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Anti-Inflammatory Interventions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Corticosteroids Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Non-Steroidal Anti-Inflammatory Drugs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Other Anti-Inflammatory Interventions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Anti-Oxidative Interventions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Other Traditional Interventions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.9. Advanced Interventions Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL OPHTHALMOLOGY CONTRACT RESEARCH ORGANIZATION MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Pharma or Biopharma Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Medical Device Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Academic Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL OPHTHALMOLOGY CONTRACT RESEARCH ORGANIZATION MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Service Type
  • 7.2.2 By Therapy
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Service Type
  • 7.3.2 By Therapy
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Service Type
  • 7.4.2 By Therapy
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Service Type
  • 7.5.2 By Therapy
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Service Type
  • 7.6.2 By Therapy
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL OPHTHALMOLOGY CONTRACT RESEARCH ORGANIZATION INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 IQVIA Holdings Inc
  • 9.2.2 ICON Plc
  • 9.2.3 Charles River Laboratories InternationalInc
  • 9.2.4 Eurofins Scientific SE
  • 9.2.5 Syneos HealthInc
  • 9.2.6 Medpace HoldingsInc
  • 9.2.7 WuXi AppTec Co.Ltd
  • 9.2.8 Parexel International Corporation
  • 9.2.9 Fortrea Holdings Inc
  • 9.2.10 Laboratory Corporation Of America Holdings (Covance)
  • 9.2.11 SGS SA (SGS Life Sciences)
  • 9.2.12 PSI CRO AG
  • 9.2.13 Worldwide Clinical Trials
  • 9.2.14 Novotech Health Holdings Pty Limited
  • 9.2.15 TFS HealthScience